Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Artivion Inc (AORT)

Artivion Inc (AORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,709,459
  • Shares Outstanding, K 47,884
  • Annual Sales, $ 441,330 K
  • Annual Income, $ 9,770 K
  • EBIT $ 34 M
  • EBITDA $ 56 M
  • 60-Month Beta 1.60
  • Price/Sales 3.88
  • Price/Cash Flow 32.05
  • Price/Book 3.73

Options Overview Details

View History
  • Implied Volatility 85.20% (-22.36%)
  • Historical Volatility 44.72%
  • IV Percentile 91%
  • IV Rank 16.59%
  • IV High 343.80% on 11/28/25
  • IV Low 33.76% on 08/12/25
  • Expected Move (DTE 23) 3.36 (9.40%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 201
  • Open Int (30-Day) 197
  • Expected Range 32.34 to 39.06

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.06
  • Number of Estimates 1
  • High Estimate 0.06
  • Low Estimate 0.06
  • Prior Year 0.06
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.81 +2.70%
on 03/24/26
38.74 -7.72%
on 03/02/26
-0.03 (-0.08%)
since 02/25/26
3-Month
33.85 +5.61%
on 02/13/26
47.06 -24.03%
on 12/26/25
-11.14 (-23.76%)
since 12/24/25
52-Week
21.97 +62.72%
on 04/09/25
48.25 -25.91%
on 12/17/25
+11.08 (+44.91%)
since 03/25/25

Most Recent Stories

More News
3 of Wall Street’s Favorite Stocks We Steer Clear Of

3 of Wall Street’s Favorite Stocks We Steer Clear Of

ZG : 45.98 (+1.97%)
AORT : 36.51 (+2.27%)
SMTC : 78.81 (+1.10%)
Envista, Baxter, Artivion, Dentsply Sirona, and Cigna Stocks Trade Down, What You Need To Know

Envista, Baxter, Artivion, Dentsply Sirona, and Cigna Stocks Trade Down, What You Need To Know

CI : 266.57 (+0.26%)
BAX : 17.08 (+2.15%)
XRAY : 11.73 (+2.27%)
NVST : 26.47 (+1.69%)
AORT : 36.51 (+2.27%)
Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

ATLANTA , March 3, 2026 /PRNewswire/ --  Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate virtually...

AORT : 36.51 (+2.27%)
5 Must-Read Analyst Questions From Artivion’s Q4 Earnings Call

5 Must-Read Analyst Questions From Artivion’s Q4 Earnings Call

AORT : 36.51 (+2.27%)
Artivion (AORT) Stock Trades Down, Here Is Why

Artivion (AORT) Stock Trades Down, Here Is Why

AORT : 36.51 (+2.27%)
AORT Q4 Deep Dive: Stent Graft and On-X Growth Offset By Tissue Flatness, Guidance Highlights Pipeline

AORT Q4 Deep Dive: Stent Graft and On-X Growth Offset By Tissue Flatness, Guidance Highlights Pipeline

AORT : 36.51 (+2.27%)
Artivion (NYSE:AORT) Misses Q4 CY2025 Sales Expectations

Artivion (NYSE:AORT) Misses Q4 CY2025 Sales Expectations

AORT : 36.51 (+2.27%)
Artivion Reports Fourth Quarter and Full Year 2025 Financial Results

Fourth Quarter Highlights:

AORT : 36.51 (+2.27%)
What To Expect From Artivion’s (AORT) Q4 Earnings

What To Expect From Artivion’s (AORT) Q4 Earnings

AORT : 36.51 (+2.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Artivion Inc. is a medical device company. It focused on developing simple, elegant solutions which address cardiac and vascular surgeons. The company's group of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts and surgical sealants....

See More

Key Turning Points

3rd Resistance Point 37.24
2nd Resistance Point 36.57
1st Resistance Point 36.14
Last Price 36.51
1st Support Level 35.04
2nd Support Level 34.37
3rd Support Level 33.94

See More

52-Week High 48.25
Fibonacci 61.8% 38.21
Last Price 36.51
Fibonacci 50% 35.11
Fibonacci 38.2% 32.01
52-Week Low 21.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.